StockNews.com initiated coverage on shares of Arch Biopartners (NYSE:ARCH – Free Report) in a research note issued to investors on Wednesday. The brokerage issued a hold rating on the stock.
Arch Biopartners Stock Performance
Shares of NYSE:ARCH opened at $134.83 on Wednesday. Arch Biopartners has a 52 week low of $116.44 and a 52 week high of $180.65.
Read More
- Five stocks we like better than Arch Biopartners
- What is the FTSE 100 index?
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- 10 Best Airline Stocks to Buy
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- What Investors Need to Know About Upcoming IPOs
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for Arch Biopartners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Biopartners and related companies with MarketBeat.com's FREE daily email newsletter.
